BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33156995)

  • 1. Application of a dermatopharmacokinetic (DPK) method for bioequivalence assessment of topical metronidazole creams.
    Rath S; Ramanah A; Bon C; Kanfer I
    J Pharm Pharm Sci; 2020; 23():437-450. PubMed ID: 33156995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioequivalence of topical clotrimazole formulations: an improved tape stripping method.
    Parfitt NR; Skinner MF; Bon C; Kanfer I
    J Pharm Pharm Sci; 2011; 14(3):347-57. PubMed ID: 21906479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of an Optimized Tape Stripping Method for the Bioequivalence Assessment of Topical Acyclovir Creams.
    Nallagundla S; Patnala S; Kanfer I
    AAPS PharmSciTech; 2018 May; 19(4):1567-1573. PubMed ID: 29484615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved bioequivalence assessment of topical dermatological drug products using dermatopharmacokinetics.
    N'Dri-Stempfer B; Navidi WC; Guy RH; Bunge AL
    Pharm Res; 2009 Feb; 26(2):316-28. PubMed ID: 18941872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the bioequivalence of topical retinoid products by pharmacodynamic assay.
    Lehman PA; Franz TJ
    Skin Pharmacol Physiol; 2012; 25(5):269-80. PubMed ID: 22847319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Approach for the Bioequivalence Assessment of Topical Cream Formulations: Model-Based Analysis of Tape Stripping Data Correctly Concludes BE and BIE.
    Ozdin D; Kanfer I; Ducharme MP
    Pharm Res; 2020 Jan; 37(2):20. PubMed ID: 31897770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are marketed topical metronidazole creams bioequivalent? Evaluation by in vivo microdialysis sampling and tape stripping methodology.
    García Ortiz P; Hansen SH; Shah VP; Sonne J; Benfeldt E
    Skin Pharmacol Physiol; 2011; 24(1):44-53. PubMed ID: 20847588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of irritant dermatitis on cutaneous bioavailability of a metronidazole formulation, investigated by microdialysis and dermatopharmacokinetic method.
    Ortiz PG; Hansen SH; Shah VP; Menné T; Benfeldt E
    Contact Dermatitis; 2008 Jul; 59(1):23-30. PubMed ID: 18537995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous Pharmacokinetics of Acyclovir Cream 5% Products: Evaluating Bioequivalence with an In Vitro Permeation Test and an Adaptation of Scaled Average Bioequivalence.
    Shin SH; Rantou E; Raney SG; Ghosh P; Hassan H; Stinchcomb A
    Pharm Res; 2020 Oct; 37(10):210. PubMed ID: 33001286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluation of three metronidazole topical products.
    Miron DS; Rădulescu FS; Benfeldt E; Shah VP; Voicu VA
    Pharm Dev Technol; 2014 Mar; 19(2):194-9. PubMed ID: 23360505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro-In Vivo Correlations (IVIVC) for Predicting the Clinical Performance of Metronidazole Topical Creams Intended for Local Action.
    Rath S; Kanfer I
    Pharmaceutics; 2023 Jan; 15(1):. PubMed ID: 36678897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of in vivo bioequivalence methodology for dermatologic corticosteroids based on pharmacodynamic modeling.
    Singh GJ; Adams WP; Lesko LJ; Shah VP; Molzon JA; Williams RL; Pershing LK
    Clin Pharmacol Ther; 1999 Oct; 66(4):346-57. PubMed ID: 10546918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of dermatopharmacokinetic approach in the bioequivalence determination of topical tretinoin gel products.
    Pershing LK; Nelson JL; Corlett JL; Shrivastava SP; Hare DB; Shah VP
    J Am Acad Dermatol; 2003 May; 48(5):740-51. PubMed ID: 12734504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gel vehicles are not inherently more irritating than creams.
    Kirkland CR; Yelverton CB; Fleischer AB; Camacho FT; Feldman SR
    J Drugs Dermatol; 2006 Mar; 5(3):269-72. PubMed ID: 16573261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioequivalence of 0.1% mometasone furoate lotion to 0.1% mometasone furoate hydrogel.
    Greive KA; Barnes TM
    Australas J Dermatol; 2016 May; 57(2):e39-45. PubMed ID: 25545549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence assessment of topical clobetasol propionate products using visual and chromametric assessment of skin blanching.
    Au WL; Skinner M; Kanfer I
    J Pharm Pharm Sci; 2008; 11(1):160-6. PubMed ID: 18445371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of topical bioequivalence using dermal microdialysis and tape stripping methods.
    Incecayir T; Agabeyoglu I; Derici U; Sindel S
    Pharm Res; 2011 Sep; 28(9):2165-75. PubMed ID: 21499834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of tape stripping with the human skin blanching assay for the bioequivalence assessment of topical clobetasol propionate formulations.
    Au WL; Skinner M; Kanfer I
    J Pharm Pharm Sci; 2010; 13(1):11-20. PubMed ID: 20456826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro-in vivo correlation study for the dermatopharmacokinetics of terbinafine hydrochloride topical cream.
    Saeheng S; Nosoongnoen W; Varothai S; Sathirakul K
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1372-7. PubMed ID: 23057672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determining bioequivalence of topical dermatological drug products by tape-stripping.
    Navidi W; Hutchinson A; N'Dri-Stempfer B; Bunge A
    J Pharmacokinet Pharmacodyn; 2008 Jun; 35(3):337-48. PubMed ID: 18465213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.